SinoMab BioScience Limited
Status: Publicly traded
Direct answer
SinoMab BioScience Limited is publicly traded on HKSE under the ticker 3681.HK.
SinoMab BioScience Limited is a biopharmaceutical enterprise that specializes in the comprehensive process of discovering, developing, producing, and marketing therapeutic solutions for various immunological disorders. Their approach predominantly involves monoclonal antibody (mAb)-based biologics. A key asset in their portfolio is SM03, an innovative anti-CD22 monoclonal antibody. This drug is currently in Phase...
Can you invest in SinoMab BioScience Limited?
Yes. SinoMab BioScience Limited is publicly traded on HKSE under the ticker 3681.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for SinoMab BioScience Limited
Detailed equity research is provided by MarketSnap.